---
title: "VSEE HEALTH INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 3.321 M"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261322983.md"
published_at: "2025-10-15T21:24:26.000Z"
---

# VSEE HEALTH INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 3.321 M

Revenue: As of FY2025 Q1, the actual value is USD 3.321 M.

EPS: As of FY2025 Q1, the actual value is USD -0.24.

EBIT: As of FY2025 Q1, the actual value is USD -1.101 M.

### Segment Revenue

-   **Technology Segment**: Total revenue for the three months ended March 31, 2025, was $2,123,871, with subscription fees contributing $827,345, professional services and other fees $896,680, and technical engineering fees $399,846.
-   **Telehealth Segment**: Total revenue for the three months ended March 31, 2025, was $1,197,614, with patient fees contributing $711,264, telehealth fees $483,850, and institutional fees $2,500.

### Operational Metrics

-   **Gross Margin**: Technology segment gross margin was $1,049,747, and Telehealth segment gross margin was $810,224 for the three months ended March 31, 2025.
-   **Operating Loss**: Technology segment operating loss was - $354,237, and Telehealth segment operating loss was - $583,174 for the three months ended March 31, 2025.

### Cash Flow

-   **Net Cash Used in Operating Activities**: For the three months ended March 31, 2025, net cash used in operating activities was - $440,493.
-   **Net Cash Used in Investing Activities**: For the three months ended March 31, 2025, net cash used in investing activities was - $11,873.
-   **Net Cash Provided by Financing Activities**: For the three months ended March 31, 2025, net cash provided by financing activities was $536,373.

### Unique Metrics

-   **Interest Expense**: Total interest expense for the three months ended March 31, 2025, was $730,665.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to leverage its industry relationships with government, hospital systems, and insurance providers to increase its customer base and expand within the telehealth market.
-   **Non-Core Business**: The company is exploring additional financing options to support its working capital needs and fund growth initiatives.

### Priority

-   The company emphasizes strategies with concrete projections, such as expanding its customer base and leveraging industry relationships, over generic statements.

### Related Stocks

- [VSEEW.US - VSEE HEALTH INC C/WTS (TO PUR COM)](https://longbridge.com/en/quote/VSEEW.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| EXCLUSIVE: Penny Stock VSEE Health Teams Up With GoMyRx To Expand Telehealth Drug Delivery | VSEE Health Inc. has partnered with GoMyRx to enhance telehealth services by integrating prescription fulfillment and me | [Link](https://longbridge.com/en/news/274981770.md) |
| VSee Health Showcases Mobile ICU Solutions for Rural Hospitals in Live Webinar | VSee Health Inc. will host a live webinar on February 4, 2026, titled "The On-Demand ICU: Sustainable Rural Healthcare." | [Link](https://longbridge.com/en/news/274164982.md) |
| What Dave (DAVE)'s Strong Q4 Preview and New Coverage Mean For Shareholders | William Blair has initiated coverage on Dave Inc. with an Outperform rating following a strong Q4 preview, indicating op | [Link](https://longbridge.com/en/news/276070511.md) |
| Auddia Stock Surges After Big Merger Deal Announcement | Auddia Inc. (NASDAQ: AUUD) shares surged 70.10% to $1.42 in premarket trading following a merger announcement with Thram | [Link](https://longbridge.com/en/news/276225287.md) |
| Demystifying Watts Water Technologies: Insights From 7 Analyst Reviews | In the latest quarter, 7 analysts reviewed Watts Water Technologies (NYSE:WTS), revealing mixed ratings. The average 12- | [Link](https://longbridge.com/en/news/275943702.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.